- Home
- WFF vs EVOK Comparison
WFF vs EVOK Comparison
Compare WFF & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WFF
- EVOK
- Stock Information
- Founded
- WFF 1984
- EVOK 2007
- Country
- WFF Malaysia
- EVOK United States
- Employees
- WFF N/A
- EVOK N/A
- Industry
- WFF Miscellaneous manufacturing industries
- EVOK Biotechnology: Pharmaceutical Preparations
- Sector
- WFF Consumer Discretionary
- EVOK Health Care
- Exchange
- WFF Nasdaq
- EVOK Nasdaq
- Market Cap
- WFF 18.3M
- EVOK 18.4M
- IPO Year
- WFF 2025
- EVOK 2013
- Fundamental
- Price
- WFF $0.63
- EVOK $10.85
- Analyst Decision
- WFF
- EVOK
- Analyst Count
- WFF 0
- EVOK 0
- Target Price
- WFF N/A
- EVOK N/A
- AVG Volume (30 Days)
- WFF 57.0K
- EVOK 246.8K
- Earning Date
- WFF 04-30-2026
- EVOK 11-13-2025
- Dividend Yield
- WFF N/A
- EVOK N/A
- EPS Growth
- WFF N/A
- EVOK N/A
- EPS
- WFF 0.00
- EVOK N/A
- Revenue
- WFF $4,572,290.00
- EVOK $14,424,652.00
- Revenue This Year
- WFF N/A
- EVOK $57.38
- Revenue Next Year
- WFF N/A
- EVOK $59.57
- P/E Ratio
- WFF $125.46
- EVOK N/A
- Revenue Growth
- WFF N/A
- EVOK 67.40
- 52 Week Low
- WFF $0.45
- EVOK $1.94
- 52 Week High
- WFF $29.26
- EVOK $10.86
- Technical
- Relative Strength Index (RSI)
- WFF 45.87
- EVOK 84.40
- Support Level
- WFF $0.52
- EVOK $10.66
- Resistance Level
- WFF $0.66
- EVOK $10.75
- Average True Range (ATR)
- WFF 0.07
- EVOK 0.06
- MACD
- WFF 0.01
- EVOK -0.08
- Stochastic Oscillator
- WFF 73.38
- EVOK 78.26
About WFF WF Holding Limited Ordinary Shares
WF Holding Ltd is a manufacturer of FRP products based in Malaysia. It has been providing high-quality and durable FRP products to various industries, including, among others, chemical processing, water and wastewater treatment, and power generation. Its products range from tanks, pipes, ducts, gratings and other custom-made FRP products. The company uses advanced production technology and equipment and has obtained various certifications. Its manufacturing capabilities allow the company to design and fabricate products that meet the specific needs of its clients, ensuring high-quality and reliable performance.
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.